EcoDrugPlus

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSOPRG00000008732
Gene Symbol: AXL
1 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOPRG00000016632
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOPRG00000013618
Gene Symbol: BCL2
1 Cross references
227 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOPRG00000004671
Gene Symbol: BCL2L1
1 Cross references
287 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSOPRG00000015895
Gene Symbol: BCL2L10
1 Cross references
129 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSOPRG00000001560
Gene Symbol: BCL2A1
1 Cross references
114 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSOPRG00000016803
Gene Symbol: BCR
1 Cross references
274 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSOPRG00000007935
Gene Symbol: BTK
1 Cross references
206 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSOPRG00000014015
Gene Symbol: CCR1
1 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSOPRG00000005040
Gene Symbol: CCR4
1 Cross references
254 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSOPRG00000011364
Gene Symbol: CCR5
2 Cross references
297 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSOPRG00000015489
Gene Symbol: CCR9
3 Cross references
262 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).